Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-α and retinoids

被引:33
作者
Brodowicz, T
Wiltschke, C
Kandioler-Eckersberger, D
Grunt, TW
Rudas, M
Schneider, SM
Hejna, M
Budinsky, A
Zielinski, CC
机构
[1] Univ Hosp Vienna, Dept Med 1, Div Clin Oncol, A-1090 Vienna, Austria
[2] Univ Hosp Vienna, Dept Med 1, Chair Med Expt Oncol, A-1090 Vienna, Austria
[3] Univ Hosp Vienna, Dept Surg, A-1090 Vienna, Austria
[4] Univ Hosp Vienna, Dept Clin Pathol, A-1090 Vienna, Austria
[5] Ludwig Boltzmann Inst Clin Expt Oncol, Vienna, Austria
关键词
apoptosis; soft tissue sarcoma; interferon-alpha; retinoids; p53;
D O I
10.1038/sj.bjc.6690528
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Uncontrolled proliferation and a defect of apoptosis constitute crucial elements in the development and progression of tumours. Among many other biological response modifiers known to influence these mechanisms, the efficacy of retinoids and interferons in the treatment of various malignant entities is currently matter of discussion. In the present study, we have investigated the effects of 9-cis-retinoic acid (9cRA), 13-cis-retinoic acid (13cRA), all-trans-retinoic acid (tRA) and interferon-alpha r on proliferation and apoptosis of human soft tissue sarcoma (STS) cell lines HTB-82 (rhabdomyosarcoma), HTB-91 (fibrosarcoma), HTB-92 (liposarcoma), HTB-93 (synovial sarcoma) and HTB-94 (chondrosarcoma) in relation to p53 genotype as well as p53 expression. HTB-91, HTB-92 and HTB-94 STS cells exhibited mutant p53, whereas wild-type p53 was found in HTB-93 STS cells, and a normal p53 status in HTB-82 STS cells, carrying a silent point mutation only. Interferon-cr, irrespective of p53 status, inhibited the proliferation of all five cell lines dose- and time-dependently Similarly, 9cRA, 13cRA and tRA decreased the proliferation of HTB-82 and HTB-93 STS cells, whereas the proliferation of p53-mutated HTB-91, HTB-92 and HTB-94 STS cells remained unchanged. Furthermore, only 9cRA and tRA were capable of inducing apoptosis in HTB-82 and HTB-93 STS cells, whereas HTB-91, HTB-92 and HTB-94 STS cells did not undergo apoptosis under the influence of 9cRA or tRA. Retinoic acid receptor (RAR)-alpha and RAR-beta mRNA were not detectable by Northern blot analysis in the five STS cell lines, whereas mRNA for the universal retinoic acid receptor, RAR-gamma, was expressed in all STS cell lines indicating that retinoid resistance was not associated with a lack of RAR expression. Apoptosis was not induced by interferon-alpha or 13cRA in any of the five STS cell lines tested. Our results indicate that within the panel of tested STS cell lines, inhibition of proliferation and induction of apoptosis result from different mechanisms which differ in their dependence upon the presence of intact p53.
引用
收藏
页码:1350 / 1358
页数:9
相关论文
共 49 条
[1]   Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients [J].
Aas, T ;
Borresen, AL ;
Geisler, S ;
SmithSorensen, B ;
Johnsen, H ;
Varhaug, JE ;
Akslen, LA ;
Lonning, PE .
NATURE MEDICINE, 1996, 2 (07) :811-814
[2]   P53 CONTROLS BOTH THE G(2)/M AND THE G(1) CELL-CYCLE CHECKPOINTS AND MEDIATES REVERSIBLE GROWTH ARREST IN HUMAN FIBROBLASTS [J].
AGARWAL, ML ;
AGARWAL, A ;
TAYLOR, WR ;
STARK, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8493-8497
[3]   AN INTERGROUP PHASE-III RANDOMIZED STUDY OF DOXORUBICIN AND DACARBAZINE WITH OR WITHOUT IFOSFAMIDE AND MESNA IN ADVANCED SOFT-TISSUE AND BONE SARCOMAS [J].
ANTMAN, K ;
CROWLEY, J ;
BALCERZAK, SP ;
RIVKIN, SE ;
WEISS, GR ;
ELIAS, A ;
NATALE, RB ;
COOPER, RM ;
BARLOGIE, B ;
TRUMP, DL ;
DOROSHOW, JH ;
AISNER, J ;
PUGH, RP ;
WEISS, RB ;
COOPER, BA ;
CLAMOND, GH ;
BAKER, LH .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1276-1285
[4]  
Antman KH, 1997, SEMIN ONCOL, V24, P556
[5]   COMPLETE SEQUENCING OF THE P53 GENE PROVIDES PROGNOSTIC INFORMATION IN BREAST-CANCER PATIENTS, PARTICULARLY IN RELATION TO ADJUVANT SYSTEMIC THERAPY AND RADIOTHERAPY [J].
BERGH, J ;
NORBERG, T ;
SJOGREN, S ;
LINDGREN, A ;
HOLMBERG, L .
NATURE MEDICINE, 1995, 1 (10) :1029-1034
[6]  
BORDEN EC, 1990, CANCER, V66, P862, DOI 10.1002/1097-0142(19900901)66:5<862::AID-CNCR2820660509>3.0.CO
[7]  
2-R
[8]  
BRACEY TS, 1995, ONCOGENE, V10, P2391
[9]   Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial [J].
Brodowicz, T ;
Kotz, R ;
Wiltschke, C ;
Zielinski, CC ;
Ritschl, P .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :2174-2174
[10]   GROWTH-FACTOR MODULATION OF P53-MEDIATED GROWTH ARREST VERSUS APOPTOSIS [J].
CANMAN, CE ;
GILMER, TM ;
COUTTS, SB ;
KASTAN, MB .
GENES & DEVELOPMENT, 1995, 9 (05) :600-611